These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 32573724)

  • 1. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
    Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
    Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
    Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
    Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
    [No Abstract]   [Full Text] [Related]  

  • 3. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why should we use convalescent plasma for COVID-19?
    Franchini M
    Eur J Intern Med; 2020 Jul; 77():150-151. PubMed ID: 32425365
    [No Abstract]   [Full Text] [Related]  

  • 7. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
    Xu TM; Lin B; Chen C; Liu LG; Xue Y
    Virol J; 2020 Jun; 17(1):80. PubMed ID: 32560646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 10. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
    Nnaji CA; Iwu CJ; Ndwandwe DE; Jordan P; Wiysonge CS
    S Afr Med J; 2020 Jul; 110(8):759-760. PubMed ID: 32880303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of COVID-19: old tricks for new challenges.
    Cunningham AC; Goh HP; Koh D
    Crit Care; 2020 Mar; 24(1):91. PubMed ID: 32178711
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
    JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Main therapeutic options.
    Hachfi W; Ben Lasfar N
    Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel Approach Using Social Media to Solve Medical Ethical Dilemmas and Legal Risks in the Emergencies of COVID-19.
    Wan J; Huang Y; Aljaafreh AAHA; Dong D; Cong Y; Lin J; Chen H
    Am J Bioeth; 2020 Jul; 20(7):W12-W14. PubMed ID: 32716772
    [No Abstract]   [Full Text] [Related]  

  • 17. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
    Garraud O
    Transfus Apher Sci; 2020 Aug; 59(4):102858. PubMed ID: 32631501
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
    Majbour N; El-Agnaf O
    Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.